mothertobaby semaglutide fact sheet pregnancy 2024 A new study found reassuring results around GLP-1 use during early — but Dr. Celine Gounder cautions that “just because the study found no clear harm does not mean the same MotherToBaby is currently enrolling pregnant

Why Muscle MattersEspecially on GLP-1s While GLP-1 drugs help with fat loss and appetite control, they dont differentiate between fat and lean muscle mass

The researchers recommended that people who already have kidney disease should be careful while taking Ozempic

Ravi Somayazulas advanced technique integrates internal shaping sutures and internal-bra support, which provide longer-lasting lift and improved scar quality

ESSENCE Phase 3 semaglutide in MASH data supported FDA approval in March 2024 , creating a premium pricing tier in a disease category with USD 17.4 billion addressable market and no prior approved pharmacotherapy